Literature DB >> 9117929

MRI and scintigraphic features of extraabdominal desmoid tumors.

H Kobayashi1, Y Kotoura, M Hosono, T Tsuboyama, H Sakahara, K Endo, J Konishi.   

Abstract

To determine whether extraabdominal desmoid can be correctly diagnosed using both magnetic resonance imaging (MRI) and scintigraphy with pentavalent technetium-99m dimercaptosuccinic acid and gallium-67 citrate, MRI (T1- and T2-weighted images) and scintigraphy were performed in 18 patients with 27 histologically proved extraabdominal desmoid tumors. The extraabdominal desmoid tumors were characterized by positive uptake of pentavalent technetium-99m dimercaptosuccinic acid and lack of uptake of gallium-67 citrate on scintigraphy. These tumors were isointense to skeletal muscle on T1-weighted MRIs and hyperintense on T2-weighted images. They also displayed septum-like internal inhomogeneity and surrounding hypointense capsular band. The combination of scintigraphy and MRI is of value in correctly diagnosing extraabdominal desmoid tumors except in the rare case of fibrotic verylow-grade sarcoma.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9117929     DOI: 10.1016/0899-7071(95)00067-4

Source DB:  PubMed          Journal:  Clin Imaging        ISSN: 0899-7071            Impact factor:   1.605


  4 in total

Review 1.  Desmoid tumours of the extremities and trunk: a review of the literature.

Authors:  Emilios E Pakos; Pericles G Tsekeris; Ann C Goussia
Journal:  Int Orthop       Date:  2005-05-18       Impact factor: 3.075

2.  [Extra-abdominal desmoid tumors. Case report and literature review].

Authors:  J Ridders; A Ernst; I Todt; R O Seidl
Journal:  HNO       Date:  2005-07       Impact factor: 1.284

3.  Intra-Abdominal Desmoid Tumour (DT) with Pelvic Extension-A Case Report.

Authors:  Sathish Selva Kumar; Padmini Ramachandran; Veena G; Napa Madhusudhan; Uday Kumbhar
Journal:  J Clin Diagn Res       Date:  2013-09-30

4.  Tumors of the peripheral nerves and plexuses.

Authors:  Jason H Huang; Victoria E Johnson; Eric L Zager
Journal:  Curr Treat Options Neurol       Date:  2006-07       Impact factor: 3.972

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.